申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10329274B2
公开(公告)日:2019-06-25
Disclosed are compounds of Formula (I):
or a salt thereof, wherein: X is CR4 or N; R1, R2, R3, R4, and A are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
公开的是式 (I) 化合物:
或其盐,其中X是CR4或N;R1、R2、R3、R4和A在本文中定义。还公开了将此类化合物用作布鲁顿酪氨酸激酶(Btk)抑制剂的方法,以及包含此类化合物的药物组合物。这些化合物可用于治疗、预防或减缓各种治疗领域的疾病或紊乱,如自身免疫性疾病和血管疾病。